Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kinnate Biopharma Q2 EPS $(0.49) Up From $(2.05) YoY

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.49) per share. This is a 76.1 percent increase over losses of $(2.05) per share from the same period last year.
byBenzinga Newsdesk
August 16, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kinnate Biopharma (NASDAQ:KNTE) reported quarterly losses of $(0.49) per share. This is a 76.1 percent increase over losses of $(2.05) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts